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Summary
The NMDA receptor (NMDAR) is a component of excit-
atory synapses and a key participant in synaptic plas-
ticity. We investigated the role of two domains in the
C terminus of the NR2B subunit—the PDZ binding do-
main and the clathrin adaptor protein (AP-2) binding
motif—in the synaptic localization of NMDA recep-
tors. NR2B subunits lacking functional PDZ binding
are excluded from the synapse. Mutations in the AP-2
binding motif, YEKL, significantly increase the num-
ber of synaptic receptors and allow the synaptic lo-
calization of NR2B subunits lacking PDZ binding.
Peptides corresponding to YEKL increase the synap-
tic response within minutes. In contrast, the NR2A
subunit localizes to the synapse in the absence of
PDZ binding and is not altered by mutations in its
motif corresponding to YEKL of NR2B. This study
identifies a dynamic regulation of synaptic NR2B-con-
taining NMDARs through PDZ protein-mediated stabi-
lization and AP-2-mediated internalization that is
modulated by phosphorylation by Fyn kinase.
Introduction
The identification of the molecular mechanisms in-
volved in the regulation of synaptic receptors is essen-
tial to understanding how synaptic plasticity is regu-
lated. Our understanding of AMPA receptor regulation
has grown in recent years as key interacting proteins
have been identified and mechanisms controlling these
interactions have been elucidated (Malinow and Ma-
lenka, 2002). Significantly less is known about the reg-
ulation of synaptic NMDA receptors. Although the
NMDAR is a relatively stable resident of the synapse
(Ehlers, 2000; Lin et al., 2000; Luscher et al., 1999), a
number of studies have shown that both the number of
receptors and their subunit compositions can be al-
tered. These changes appear to be mediated in a num-
ber of ways including changes in synthesis and degra-
dation (Ehlers, 2003; Follesa and Ticku, 1996; Rao and
Craig, 1997), lateral diffusion within the membrane (To-
var and Westbrook, 2002), and alterations in receptor
trafficking (Crump et al., 2001; Rao and Craig, 1997; Sny-*Correspondence: prybylow@nidcd.nih.govder et al., 2001; Watt et al., 2000, reviewed in Choquet
and Triller, 2003). Recent studies have also shown that
both synaptic and extrasynaptic NMDARs can be regu-
lated by clathrin-mediated internalization (Li et al.,
2002; Montgomery and Madison, 2002; Nong et al.,
2003, 2004; Roche et al., 2001; Snyder et al., 2001; Vis-
sel et al., 2001). This was first suggested by Vissel et
al. (2001), who identified a motif in the proximal region
of the carboxy terminus of NR2A that regulated use-
dependent internalization of the receptor. Nong et al.
(2003) showed that glycine could prime NMDARs for
internalization, and Li et al. (2002) suggested that endo-
cytosis was involved in rundown of extrasynaptic
NMDARs.
Previous work identified an AP-2 binding site that
functions as an internalization motif, YEKL (Figure 1A),
that is important in regulating surface expression of
constructs containing the distal C terminus of the NR2B
subunit (Roche et al., 2001). However, this study did not
address the questions of whether or not internalization
involving the YEKL motif played a role in controlling
synaptic receptors or if only extrasynaptic receptors
were regulated in this fashion. The age-dependent de-
crease in the internalization of NMDARs in cultured
neurons was consistent with internalization restricted
to extrasynaptic receptors. In the present study, we in-
vestigated the molecular basis of NMDAR internaliza-
tion and the role of PDZ proteins in regulating synaptic
NMDARs. We find that three processes, PDZ anchor-
ing, AP-2-mediated internalization, and phosphoryla-
tion of Y1472 together play a key role in the regulation
of NR2B-containing synaptic NMDARs.
Results
Mutation at Y1472 of NR2B Increases the Number
of Synaptic NMDARs
We used cerebellar granule cells (CGCs) in culture, a
system that allows precise analysis of functional
NMDARs that form when transfected NR2 subunits
coassemble with the native NR1 subunit population
(Prybylowski et al., 2002). Expression of NR2B WT
caused an increase in the current density in response
to applied NMDA (200 M NMDA/20 M D-serine), as
previously shown (Prybylowski et al., 2002). Expression
of Y1472A caused a significant increase in the current
density, which was not different from NR2B WT expres-
sion (Figures 1A–1C). Experiments in HEK cells also in-
dicated similar surface expression levels and cell death
(data not shown). Therefore, a similar number of total
surface NMDARs are present with expression of either
Y1472A or NR2B WT.
We then analyzed NMDA miniature excitatory post-
synaptic currents (NMDA-mEPSCs) in transfected CGCs.
Expression of NR2B WT caused a slowing of the deacti-
vation kinetics of the NMDA-mEPSC (due to the slow
kinetics of NMDARs containing the NR2B subunit [Cull-
Candy et al., 2001]) without a change in the amplitude
of response (Figures 1D–1F). This indicates that NR2B-
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846Figure 1. Expression of an NR2B Subunit
with a Mutation at Y1472 Causes a Specific
Increase in NMDA-mEPSC Amplitude
(A) The amino acid sequence of the distal C
terminus of the NR2B subunit. Two motifs
are underlined, a consensus internalization
motif for AP-2 binding (YEKL, aa 1472–1475)
and the PDZ binding domain that mediates
MAGUK binding (SDV, aa 1480–1482). Amino
acids 1472, 1475, and 1480 are sites where
mutations were made. (B) Representative
traces from individual control CGC or indivi-
dual CGC transfected with cDNAs for wild-
type or mutant subunits of the NMDAR.
Whole-cell recordings were done 48 hr after
transfection with application of 200 M
NMDA and 20 M D-serine with 1 M TTX in
Mg2+-free solution. (C) Summary of current
density responses from multiple CGCs (con-
trol, n = 10; NR2B WT, n = 12; Y1472A, n =
15). Transfection with either NR2B WT or
Y1472A caused a similar, significant increase
in the current density of response (*p < 0.01).
(D) Top traces, representative raw traces
from transfected CGCs. Bottom traces, re-
presentative NMDA-mEPSCs averaged from
individual control or transfected (with NR2B
WT or Y1472A) CGCs. Recordings were
made in Mg2+-free extracellular solution with
50 M bicuculline, 1 M TTX, and 10 M
NBQX. (E) Average amplitude of NMDA-
mEPSCs from multiple CGCs (control, n =
25; NR2B WT, n = 15; Y1472A, n = 20). Ex-
pression of NR2B WT caused no change in
amplitude compared to untransfected
CGCs, but expression of Y1472A caused a
significant increase (*p < 0.01). (F) Average
of the weighted time constant of decay (τw)
from multiple CGCs. Expression of either
NR2B WT or Y1472A caused a significant
slowing of the deactivation kinetics of the
NMDA-mEPSCs (*p < 0.01). Error bars repre-
sent mean ± SEM.containing receptors entered the synapse, which was
previously confirmed by an increase in the ability of a
NR2B-selective antagonist to block NMDA-mEPSCs
(Prybylowski et al., 2002). In contrast to NR2B WT, ex-
pression of Y1472A caused both an increase in the am-
plitude and a slowing of the deactivation kinetics of the
NMDA-mEPSC (Figures 1D–1F). Statistical analyses in-
dicate that NMDA-mEPSCs from Y1472A-transfected
CGCs were larger than both control and NR2B WT-
transfected CGCs (p < 0.01). There was no significant
change in the frequency of NMDA-mEPSCs among the
different groups (control, 0.07 ± 0.01 Hz; 2B WT, 0.07 ±
0.01 Hz; Y1472A, 0.07 ± 0.01 Hz). Because of the low
background noise, single-channel currents could be di-
rectly resolved from the tails of NMDA-mEPSCs (Pryby-
lowski et al., 2002; Silver et al., 1992). Single-channel
currents measured in untransfected and Y1472A-trans-
fected CGCs (4.0 ± 0.2 pA and 4.0 ± 0.3 pA, respec-
tively, from at least 10 cells) were not different. Although
we measured conductances of NMDARs that are pre-
sumably synaptic, it has been previously shown that syn-
aptic and extrasynaptic NMDARs have similar conduc-






















where was also no difference in agonist affinity between
R2B WT and Y1472A, and similar results were ob-
ained with mutation of Y1472G compared to Y1472A
data not shown). Although synaptic NMDARs may not
e saturated by glutamate release by a single vesicle,
larger receptor pool would increase the amplitude of
esponse independently of whether the receptor pool
s saturated. In addition, a change in the open prob-
bility of the receptor would likely cause a change in
he response to agonist, which is the same for 2B WT
nd Y1472A. The increased NMDA-mEPSC amplitude
ithout a change in single-channel conductance, there-
ore, suggests that NR2B-containing NMDARs with muta-
ion at Y1472 are increased in number at the synapse
ompared to those containing NR2B WT subunits.
elationship of the PDZ Binding Domain
nd AP-2-Dependent Internalization
he increased NMDA-mEPSC amplitude of Y1472A
ithout a corresponding change in the current density
f response to NMDA (which measures both synaptic
nd extrasynaptic NMDARs) suggests that the change
as limited to the synapse. Deletion of the PDZ binding
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847domain causes a decreased synaptic localization of
NR2B-containing NMDARs (Barria and Malinow, 2002;
Prybylowski et al., 2002; Steigerwald et al., 2000), so
we tested the impact of Y1472A mutation on the traf-
ficking of NMDARs in conjunction with mutations that
disrupt PDZ binding. The S1480A mutation dramatically
decreases the affinity of the NR2B C terminus for the
PDZ domains of MAGUKs (Lim et al., 2002). As ex-
pected, receptors containing the mutant S1480A NR2B
subunit did not localize to the synapse, as shown by
their inability to slow the deactivation kinetics of the
NMDA-mEPSC, in contrast to NR2B WT (Figures 2A1–
2A3). S1480A had normal surface expression in CGCs
(current densities of response to NMDA application
were 173 ± 8 pA/pF and 188 ± 20 pA/pF for NR2B WT
[n = 12] and S1480A-transfected [n = 6] CGCs, respec-
tively), indicating that the PDZ binding domain is not
required for extrasynaptic receptor delivery (Prybylow-
ski et al., 2002; Steigerwald et al., 2000).
We then tested an NR2B construct with a double mu-
tation at both Y1472A and S1480A (Y1472A/S1480A),Figure 2. Normal PDZ binding Is Not Neces-
sary for the Synaptic Localization of NR2B-
Containing NMDARs If AP-2 Binding Is
Blocked
(A1) Representative NMDA-mEPSCs were
recorded from individual control or trans-
fected CGCs. Y1472A/S1480A, L1475A/
S1480A, and Y1472A/1481stop (lacking the
last amino acid of NR2B) represent double
mutations in NR2B. (A2) Average of the
NMDA-mEPSC amplitude from multiple
CGCs. Expression of NR2B WT (n = 15) or
S1480A (n = 16) did not alter NMDA-mEPSC
amplitude compared to control (n = 25). Ex-
pression of Y1472A (n = 20), Y1472A/S1480A
(n = 15), Y1472A/1481stop (n = 12), or
L1475A/S1480A (n = 19) significantly in-
creased NMDA-mEPSC amplitude com-
pared to control (*p < 0.05). (A3) Average of
the weighted time constants of decay (τw).
Expression of NR2B WT, Y1472A, Y1472A/
S1480A, L1475A/S1480A, or Y1472A/
1481stop significantly slowed the NMDA-
mEPSC deactivation kinetics compared to
control (*p < 0.01). Expression of S1480A did
not alter NMDA-mEPSC deactivation kinet-
ics compared to control. (B) Deoxycholate-
solubilized samples from HEK 293 cells were
incubated with anti-PSD-95 antibody or non-
specific IgG coupled to Protein A agarose.
Input and pellet samples were used for
Western blot. Images are representative of
three independent experiments. (C1) CGCs
were transfected either with S1480A alone or
together with the 2 WT or 2W421A AP-2
subunits. Recordings were made at least 3
days after transfection, and representative
NMDA-mEPSCs are shown. (C2) Averaged
amplitude of NMDA-mEPSCs from multiple
CGCs. Coexpression of 2W421A with
S1480A (n = 18) significantly increased
NMDA-mEPSC amplitude (p < 0.05). Coex-
pression of 2 WT with S1480A (n = 10)
caused no change in amplitude compared to
S1480A expression alone (n = 16). (C3) Average of the weighted time constant of decay (τw) from multiple CGCs. Coexpression of 2W421A
with S1480A significantly slowed the NMDA-mEPSC deactivation kinetics compared to S1480A alone (p < 0.05). Coexpression of 2 WT with
S1480A caused no change. Error bars represent mean ± SEM.disrupting both the AP-2 and the PDZ binding motifs.
Agonist (200M NMDA/20 M D-serine) response from
cells expressing Y1472A/S1480A was not different from
NR2B WT (173 ± 8 pA/pF and 165 ± 4 pA/pF for NR2B
WT [n = 12] and Y1472A/S1480A [n = 6], respectively),
indicating normal total surface expression and no
change in functional properties of the NR2B subunit.
Y1472A/S1480A caused a significant slowing of the de-
activation kinetics as well as an increase in the am-
plitude of the NMDA-mEPSC (Figures 2A1–2A3). As
shown in Figure 2A1, NMDA-mEPSCs from Y1472A/
S1480A-transfected CGCs closely resembled Y1472A-
transfected CGCs. This result was reproduced with an-
other double mutant, Y1472A/1481stop, which lacks
the last amino acid of the NR2B subunit (V1482) that is
critical for PDZ binding (Hung and Sheng, 2002).
Y1472A/1481stop also caused both a slowing of the
deactivation kinetics as well as an increased amplitude
of the NMDA-mEPSC (Figures 2A1–2A3).
Since Y1472 of NR2B may be associated with func-
tions in addition to mediating the interaction with AP-2,
Neuron
848we studied the other critical amino acid of the YXXf
consensus site, L1475 (Bonifacino and Traub, 2003).
Mutation of this site to a nonpermissive amino acid
should have an effect similar to that of Y1472A muta-
tion if the results obtained from the latter mutation were
due to the disruption of AP-2 binding. L1475A/S1480A
also slowed the deactivation kinetics and caused an
amplitude increase of the NMDA-mEPSC (Figure 2A).
These results showed that mutation of the AP-2 binding
site of NR2B, without altering Y1472, could compen-
sate for the loss of the PDZ binding domain and allow
localization of NR2B-containing NMDARs at the synapse.
It is possible that mutation of the AP-2 binding site
created a novel interaction between PDZ proteins and
the NR2B subunit. To address this, we expressed PSD-
95-GFP and NR1-1a with WT and mutated NR2B sub-
units in HEK 293 cells and analyzed their coimmuno-
precipitation. As seen in Figure 2B, NMDAR subunits
containing the S1480A mutation or the double mutation
Y1472A/S1480A in the NR2B subunit showed no signifi-
cant interaction with PSD-95. Although the mutation
Y1472A/S1480A does not bind well to PSD-95, we can-
not rule out that this construct has novel protein-pro-
tein interactions. We therefore tested the effect of al-
tering interactions with AP-2 more directly using a
dominant-negative construct of the 2 subunit.
The 2 subunit of the AP-2 complex has been shown
to interact with the YXXf consensus motif (Nakatsu and
Ohno, 2003). Using a yeast two-hybrid assay, we
verified that the mutations in the AP-2 binding motif
(either Y1472A or L1475A), with or without mutation of
S1480A, blocked the interaction with the 2 subunit of
AP-2 (data not shown). We cotransfected S1480A with
2 WT and 2 W421A subunits into CGCs to confirm
the role of the AP-2 complex in regulating NR2B local-
ization. 2 W421A has been previously shown to block
internalization of proteins with tyrosine-based internal-
ization motifs through the AP-2 complex (Nesterov et
al., 1999; Vissel et al., 2001). Therefore, 2 W421A can
be used to characterize the role of AP-2-dependent in-
ternalization due to tyrosine motifs. Coexpression of 2
WT had no effect in S1480A-transfected CGCs (Figure
2C). However, coexpression of 2 W421A caused a sig-
nificant increase in the deactivation kinetics and ampli-
tude of NMDA-mEPSCs in S1480A-transfected CGCs
(Figure 2C). Therefore, NR2B-containing NMDARs that
lack normal PDZ binding are able to localize to the syn-
apse if AP-2-dependent internalization is blocked. Ex-
pression of 2 W421A also caused a smaller but signifi-
cant increase in the NMDA-mEPSC amplitude in CGCs
that were not transfected with exogenous NMDAR sub-
units (22.0 ± 0.4 pA versus 19.9 ± 0.2 pA, for 2 W421A
[n = 10] and control [n = 23], respectively; p < 0.05,
Student’s t test), suggesting that endogenous synaptic
NMDARs are also regulated by internalization.
Immunostaining of NR2B-Containing Receptors
To provide an independent means of examining the ef-
fect of mutations of the NR2B subunit on its synaptic
localization and to verify that differences in subunit traf-





























































Wmunocytochemistry was performed using cultures ofippocampal neurons (Figure 3). In all studies (electro-
hysiology and immunocytochemistry), we used NR2B
onstructs that were epitope-tagged in the extracellular
omain to allow surface labeling of receptors in intact
eurons (as described in Prybylowski et al., 2002). As
R2B is retained in the endoplasmic reticulum in the
bsence of coassembly with NR1 (McIlhinney et al.,
998), surface NR2B staining is an indicator of the loca-
ion of the assembled NR1/NR2 complex. The distribu-
ion of surface-labeled NR2 subunits was compared to
hat of the presynaptic marker, Bassoon.
Neurons transfected with Y1472A or Y1472A/S1480A
ad a significantly higher density and intensity of den-
ritic Flag-stained puncta compared to neurons trans-
ected with NR2B WT or S1480A (Figure 3). Neurons
ransfected with Y1472A or Y1472A/S1480A also had a
ignificantly greater Bassoon colocalization than 2B
T. This fits well with our data showing increased
MDA-mEPSC amplitude in CGCs transfected with
1472A or Y1472A/S1480A and suggests that this in-
reased amplitude is due to an increased number of
eceptors at the synapse. With transfection of S1480A,
e saw a decrease in puncta density and intensity in
he dendrite. The strong decrease in S1480A in the den-
rite (as determined by intensity and density) suggests
hat this construct does not compete well against en-
ogenous receptors for localization in the dendrites, in
greement with a previous report that an NR2B subunit
ith decreased PDZ binding showed decreased punc-
ate surface dendritic staining (Chung et al., 2004). Our
ata also may reflect a decreased clustering of extra-
ynaptic receptors and the resulting lack of detection
y immunocytochemistry since the S1480A construct
ives the same number of total functional receptors as
he other constructs in cerebellar granule cells (Figure
). While there is a loss of expression of S1480A in the
unctional pool of synaptic receptors, as measured by
MDA-mEPSCs (Figure 2), there was still colocalization
f S1480A with Bassoon (Figure 3).
The increased density of puncta and the increased
ntensity of surface staining associated with Bassoon in
eurons transfected with Y1472A and Y1472A/S1480A
ompared to those transfected with NR2B WT or S1480A
irectly support our electrophysiological results. In par-
icular, we see that the Y1472A/S1480A subunit shows
ncreased puncta density and intensity as well as in-
reased colocalization with Bassoon compared to
1480A. This fits well with our electrophysiological data
hat indicate that the double mutation at Y1472A/
1480A allows NR2B localization at the synapse in
omparison to S1480A, which is excluded from NMDA-
EPSCs. The continued colocalization of S1480A with
resynaptic markers is likely due to the inability of im-
unocytochemistry to differentiate between synaptic
eceptors and receptors found elsewhere on the den-
ritic spine, including perisynaptic and extrasynaptic
eceptors. Previous studies (Barria and Malinow, 2002)
ave shown that deletion of the PDZ binding domain of
R2B decreases its synaptic localization but not nec-
ssarily its perisynaptic or extrasynaptic localization.
Peptide Including the YEKL Motif of NR2B
ncreases Synaptic NMDA Receptors
e then explored the possibility that AP-2 binding to
NR2B could be competed by a peptide that contains
Regulation of NR2B-Containing NMDA Receptors
849Figure 3. Domains in the Distal C Terminus
of NR2B Control Its Localization
(A) Hippocampal neurons were transfected
with NR2B constructs containing an extra-
cellular Flag epitope (the same constructs
that were used for electrophysiology experi-
ments). Surface staining was done with Flag
antibody (in red), followed by fixation and
permeabilization, and then staining was
done for the presynaptic marker protein,
Bassoon (in green). Scale bar, 10 m. (B)
Dendritic puncta were analyzed after trans-
fection with different constructs. Five den-
dritic sections were measured and averaged
to give a value for each cell included. At least
11 cells were counted from two separate
transfections for each group. In comparison
to NR2B WT, the S1480A mutant showed a
decrease in intensity while Y1472A and
Y1472A/S1480A showed an increase in in-
tensity (*p < 0.05). Y1472A/S1480A shows a
significantly greater puncta intensity com-
pared to S1480A (#p < 0.01, Student’s t test).
(C) Colocalization of Flag puncta to Bassoon
puncta was measured. Value is given in per-
cent colocalization (defined as the number
of Flag puncta overlapping or adjacent to
Bassoon puncta, divided by the total number
of Flag puncta). In comparison to 2B WT,
Y1472A and Y1472A/S1480A show increased
colocalization with Bassoon, while the S1480A mutant does not show a significant difference. There was a significant difference in percent
colocalization with Bassoon in comparing S1480A and Y1472A/S1480A (Student’s t test, #p < 0.01). (D) The Y1472A and Y1472A/S1480A
mutants show increased density (number of puncta/10 m) of puncta compared to 2B WT, while the S1480A mutant shows decreased density
of puncta. In comparison to the S1480A mutant, the Y1472A/S1480A showed significantly higher density of puncta (Student’s t test, #p <
0.01). Error bars represent mean ± SEM.the distal C terminus of NR2B including the YEKL motif
but without the PDZ binding domain (NGHVYEKLSSIE,
the YEKL peptide). In particular, this study could mea-
sure changes in endogenous receptors without expres-
sion of exogenous subunits. Our control was the iden-
tical peptide with a substitution of alanine at the
tyrosine residue (NGHVAEKLSSIE, the AEKL peptide),
which would not compete for AP-2 binding to NR2B.
Inclusion of the AEKL or YEKL peptide did not cause
any change in the response to NMDA over 20 min (5 s
application of 200 M NMDA/20 M D-serine given ev-
ery minute, Figure 4A). In recordings of NMDA-mEPSCs
made with the YEKL peptide, there was an increase in
amplitude in events recorded from 10–15 min com-
pared to those recorded at 0–5 min after the start of the
whole-cell recording (Figures 4B and 4C, p < 0.05). In
contrast, there was no change in the amplitude of
NMDA-mEPSCs recorded with the AEKL peptide over
20 min. The amplitude of NMDA-mEPSCs recorded at
10–15 min also was significantly larger for cells in which
the YEKL peptide was included compared to the ampli-
tude for cells with the AEKL peptide (p < 0.05, Student’s
t test). These data suggest that competition of binding
of AP-2 to the NR2B tail can regulate synaptic NMDA
receptors on a relatively rapid time scale.
Regulation of NMDARs by Fyn Kinase
Phosphorylation of the tyrosine residue of the YXXf
motif has been shown to block binding of AP-2 (Boni-
facino and Traub, 2003; Owen and Evans, 1998). As
Y1472 of NR2B is phosphorylated by Fyn kinase (Naka-
zawa et al., 2001), we hypothesized that phosphoryla-tion of this residue would affect the synaptic localiza-
tion of NMDARs. In HEK 293 cells, coexpression of Fyn
Y531F, a constitutively active Fyn, with NR1 and NR2B
caused a significant increase in tyrosine phosphoryla-
tion of the NR2B subunit (using immunoprecipitation of
NR2B and immunoblotting with the anti-phosphotyro-
sine antibody, 4G10 [data not shown]).
Expression of Fyn Y531F increased the amplitude of
NMDA-mEPSCs with no change in the deactivation ki-
netics of the response, suggesting that a change oc-
curred at synaptic NMDARs (Figure 5). There was no
change in the single-channel current of cells expressing
Fyn Y531F (4.1 ± 0.2 pA and 4.2 ± 0.2 pA for control
and Fyn Y531F, respectively; data from at least seven
cells). Previous studies in heterologous systems indi-
cated that recombinant NR1/NR2B receptors are not
regulated by Fyn (Kohr and Seeburg, 1996), and ex-
pression of Fyn Y531F did not cause a change in the
response to agonist (current density of 107 ± 9 pA/pF
and 104 ± 15 pA/pF for control [n = 15] and Fyn Y531F-
transfected [n = 8], respectively), supporting the idea that
there is no change in functional properties of the total
NMDAR pool. Therefore, phosphorylation of NMDARs by
Fyn increases the number of synaptic NMDARs.
The ability of Fyn Y531F to increase the number of
synaptic NMDARs suggested that it might also promote
the synaptic localization of NMDARs lacking a PDZ
binding domain. Coexpression of S1480A with Fyn
Y531F caused an increase in the amplitude and deacti-
vation kinetics of the NMDA-mEPSC (Figures 5A–5C),
indicating that tyrosine phosphorylation is sufficient to
allow the synaptic localization of NR2B subunits lack-
Neuron
850Figure 4. A Peptide Containing the Distal Tyrosine Motif of NR2B
Increases the Amplitude of NMDA-mEPSCs
(A) Responses were recorded with inclusion of peptide in the re-
cording solution. YEKL peptide (NGHVYEKLSSIE) contains the dis-
tal tyrosine motif of NR2B, while AEKL peptide (NGHVAEKLSSIE)
lacks the critical tyrosine for binding to AP-2. Responses to a 1 s
application of 200 M NMDA/20 M D-serine were measured every
minute (control equals value of first response). Responses within
the time periods were averaged for each cell (n = 7 for YEKL; n = 9
for AEKL). (B) Representative NMDA-mEPSCs were recorded and
averaged from CGCs during different times of recording. (C)
Average of the NMDA-mEPSC amplitude (from data pooled during
time periods) from multiple CGCs. While there was no statistical
change in the amplitude of recordings over time with the AEKL
peptide (n = 8), inclusion of the YEKL peptide (n = 7) in the record-
ing pipette caused an increase in the amplitude of NMDA-mEPSCs
in the time frame of 10–15 min compared to YEKL 0–5 (*p < 0.05).
The amplitude of NMDA-mEPSCs at 10–15 min was significantly
larger for YEKL than for AEKL (#p < 0.05, Student’s t test). Error

























































ing PDZ binding domains. Coexpression of Fyn Y531F
with NR2B WT also caused an increase in NMDA-
mEPSC amplitude that was not present with expression




fcreased amplitude of NMDA-mEPSCs in CGCs ex-ressing Y1472A together with Fyn Y531F compared to
hose without Fyn. Therefore, mutation at Y1472A and
ncreased tyrosine phosphorylation of the NR2B sub-
nit do not have an additive effect on NMDA-mEPSC
mplitude.
ynaptic Localization of NR2A-Containing NMDARs
s Not controlled by the PDZ Binding Domain
r the Distal Tyrosine Motif
here are multiple reports that the synaptic trafficking
nd localization of NR2A- and NR2B-containing NMDARs
re different and that these subunit differences are reg-
lated by development and activity (Barria and Mali-
ow, 2002; Rumbaugh and Vicini, 1999; Tovar and
estbrook, 1999; for review of the topic, Prybylowski
nd Wenthold, 2004). We thus assessed whether the
P-2 binding that regulates the NR2B subunit also con-
rols the NR2A subunit. Because receptors containing
he NR2A subunit are characterized by relatively fast
eactivation kinetics compared to those containing
ther NR2 subunits (Cull-Candy et al., 2001), entry of
R2A WT into the synapse is accompanied by a speed-
ng of the deactivation kinetics of the NMDA-mEPSC,
s shown in Figure 6B. Thus, faster deactivation kinet-
cs of NMDA-mEPSCs is a marker of the synaptic local-
zation of the NR2A subunit. An S1462A mutant of
R2A was studied with mutation of the serine in the
DZ binding domain. S1462A mutation of NR2A corres-
onds to S1480A mutation of NR2B, as the NR2A and
R2B subunits have identical PDZ binding domains,
DV, at their distal C termini (see Figure 6A). S1462A
xpression produces NMDA-mEPSCs with significantly
aster deactivation kinetics than control. The deactiva-
ion kinetics of S1462A was indistinguishable from
hose obtained with NR2A WT (Figures 6B and 6D).
hus, unlike the exclusion of NR2B subunits lacking
DZ binding domains (S1480A) from the synapse (Fig-
re 2), NR2A subunits lacking a PDZ binding domain
till localize to the synapse.
Since the synaptic exclusion of NR2B subunits lack-
ng PDZ binding domains can be reversed by disruption
f AP-2 binding to the YEKL motif of NR2B (Figure 2),
e hypothesized that NR2A subunits lacking a PDZ
inding domain localize to the synapse because NR2A-
ontaining NMDARs are not controlled by AP-2 binding
o a distal consensus tyrosine motif YKKM containing
1454 (which has been shown to poorly bind the 2
ubunit of AP-2 [Lavezzari et al., 2004]). We found that
xpression of an NR2A mutant at Y1454A (the distal
yrosine corresponding to Y1472 in NR2B) produced
ast NMDA-mEPSCs similar to NR2A WT, with no
hange in the amplitude from control or NR2A WT (Fig-
re 6). Thus, mutation of the YKKM motif of the NR2A
ubunit does not promote the synaptic localization of
MDARs, suggesting that the distal tyrosine motif of
R2B is a subunit-specific regulator of NMDAR local-
zation.
Since normal PDZ binding is necessary for localizing
R2B, but not NR2A, to the synapse, this difference
ould be due to the differences in amino acids between
R2B and NR2A in the distal C terminus (Figure 6A).
e generated a construct, 2AMut5, which is NR2A with
ive amino acid mutations to create a sequence iden-
tical to that of NR2B in its last 16 amino acids (five
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tion Promotes the Synaptic Localization of
NMDARs
(A) Representative NMDA-mEPSCs were re-
corded and averaged from individual control
or transfected CGCs, as described in Figure
1. (B) Average of the NMDA-mEPSC ampli-
tude from multiple CGCs. Expression of
S1480A (n = 16) caused no change in NMDA-
mEPSC amplitude. Expression of Fyn Y531F
alone (n = 17) or with any of the NR2B
constructs significantly increased NMDA-
mEPSC amplitude compared to control (*p <
0.05). Expression of FynY531F increased the
amplitude of NMDA-mEPSCs compared to
control (#p < 0.05, Student’s t test). Coex-
pression of Fyn Y531F together with S1480A
(n = 19) or NR2B WT (n = 10) caused a signifi-
cant increase in the NMDA-mEPSC ampli-
tude in comparison with the effect of the
NR2B subunit alone (#p < 0.05; Student’s t
test). Coexpression of Fyn Y531F with
Y1472A (n = 6) did not cause any change in
comparison with the effect of Y1472A alone
(n = 20). (C) Average of the weighted time
constants of decay (τw). Expression of
S1480A or Fyn Y531F alone did not alter
NMDA-mEPSC deactivation kinetics. Ex-
pression of NR2B WT or Y1472A significantly
slowed the deactivation kinetics of the re-
sponse (*p < 0.05) with no change with coex-
pression with Fyn Y531F. Coexpression of
Fyn Y531F with S1480A significantly slowed
the deactivation kinetics of NMDA-mEPSCs
compared to control (*p < 0.05) or S1480A
alone (#p < 0.01, Student’s t test). Error bars
represent mean ± SEM.amino acids were mutated: R1451G, R1452H, K1455E,
M1457L, and P1458S; Figure 6A). 2AMut5 entered the
synapse as measured by the fast deactivation kinetics
of NMDA-mEPSCs in CGCs transfected with this con-
struct compared to control. These deactivation kinetics
with 2AMut5 were not statistically different from those
of NR2A WT (Figure 6D). Thus, NR2A can enter the syn-
apse with the distal amino acids of NR2B.
To investigate whether 2AMut5 is dependent upon
PDZ binding for localization at the synapse as is NR2B,
we generated 2AMut6, which has the five mutations
present in 2AMut5 as well as a mutation of the serine
of the PDZ binding domain (S1462A). We found that
expression of any of the NR2A constructs caused a
similar increase in the whole-cell response, indicating
similar surface expression levels (current density after
application of 200 M NMDA/20 M D-serine of 108 ±
8 pA/pF for control [n = 15]; 176 ± 17 for 2A WT [n =
10]; 178 ± 28 for S1462A [n = 6]; 178 ± 20 for Y1454A
[n = 7]; 173 ± 20 for 2AMut5 [n = 11]; 175 ± 21 for
2AMut6 [n = 6]). In 2AMut6-transfected CGCs, therewas no change in the deactivation kinetics of NMDA-
mEPSCS in CGCs compared to control, indicating that
this 2AMut6 subunit does not localize at the synapse,
unlike NR2A WT (Figure 6). The deactivation kinetics of
NMDA-mEPSCs from CGCs transfected with NR2A WT,
S1462A, Y1454A, or 2AMut5 were significantly faster
than 2AMut6-transfected CGCs (Figure 6D). We also
find that while 2A WT shows little binding to the 2
subunit of AP-2 in a yeast two-hybrid assay, 2AMut5
shows increased binding comparable to that seen for
the NR2B subunit (data not shown). Therefore, amino
acid differences between NR2A and NR2B in their distal
C terminus dictate their AP-2 binding and trafficking
properties.
Discussion
Our results show that stabilization through a PDZ pro-
tein and internalization through an interaction with
AP-2 are important determinants of the number and
composition of synaptic NR2B-containing NMDARs.
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852Figure 6. Localization of NR2A at the Synapse Is Independent of
the Mechanisms Regulating NR2B
(A) Comparison of the amino acid sequences of the distal C termini
of the NR2A and NR2B subunits. Both contain a tyrosine-based
motif that fits the consensus for binding of the 2 subunit of AP-2
(YEKL, 1472–1475 for NR2A; YKKM, 1454–1457 for NR2B). NR2A
and NR2B have identical PDZ binding domains, SDV, as their distal
three amino acids. From NR2A WT, S1462A (within the PDZ binding
domain) and Y1454A (within the consensus internalization motif)
were generated at the corresponding amino acids to NR2B S1480A
and Y1472A. NR2AMut5 is a mutation of NR2A, in which the 16
distal amino acids in NR2A are converted to the corresponding
amino acids in NR2B (five amino acids were mutated: R1451G,
R1452H, K1455E, M1457L, and P1458S). NR2AMut6 has the five
mutations present in NR2AMut5, plus a mutation of the serine of
the PDZ binding domain (S1462A). (B) Representative NMDA-
mEPSCs were recorded and averaged from individual control or
transfected CGCs, as described in Figure 1. CGCs transfected with
various NR2A constructs were compared to control. (C) Average of




























































cith NMDARs through extracellular domains.
ny of these NR2A constructs did not alter the amplitude of the
MDA-mEPSC compared to that of control, untransfected CGCs
numbers given below). Bar labels are provided in (D). (D) Average
eactivation kinetics of NMDA-mEPSCs from multiple CGCs. Ex-
ression of NR2A WT (n = 8), S1462A (n = 12), Y1454A (n = 9), or
R2Mut5 (n = 8) produced NMDA-mEPSCs that were significantly
aster than control (*p < 0.05). NR2AMut6 (n = 13) expression pro-
uced NMDA-mEPSCs that were not significantly different from
hose in control (n = 13) CGCs. In comparison to NR2AMut6, the
ther NR2A constructs were significantly faster (#p < 0.05), while
ontrol was no different. Error bars represent mean ± SEM.1472 of NR2B, in addition to being a critical residue
f the AP-2 binding motif, is also a substrate for Fyn
inase-dependent phosphorylation, providing a mecha-
ism for rapid modulation of synaptic receptors. These
indings suggest a model for regulation of NR2B-con-
aining NMDARs, which links phosphorylation, internal-
zation, and PDZ protein interactions (Figure 7). Since
eceptors containing the NR2A subunit are not regu-
ated in a similar manner, these events may play a key
ole in subunit-specific trafficking of NMDARs.
egulation of NR2 Subunits by PDZ Interactions
lthough not directly proven, it is generally thought that
ynaptic NMDARs are retained at the synapse by an
ttachment to PSD-95 (or another PSD-95 family mem-
er) through a PDZ interaction with the NR2 subunits
Scannevin and Huganir, 2000). Removal of the receptor
ould require either breaking the PDZ interaction or
emoval of the PDZ protein (which may include associ-
ted proteins) along with the NMDAR. Recent work
as shown that the affinity of the PDZ interaction can
e altered by activity-dependent phosphorylation of
er1480 by casein kinase II, suggesting that the binding
f the NMDAR to PDZ proteins is a regulated process
Chung et al., 2004). In addition, cotransfection with
SD-95 can slow the internalization rate of chimeras
ontaining the tail of the C terminus of the NR2B sub-
nit (Roche et al., 2001). These data support the idea
hat maintenance of the PDZ interaction is a critical
tep in keeping NMDA receptors at the synapse and
hat disrupting this interaction may be the first step in
he removal of the receptor. Our data show that an in-
eraction of the NR2B subunit with AP-2 is also required
or removal, indicating that internalization is a dominant
egulator of NR2B-containing receptors at the synapse.
ur results, however, also suggest that the PDZ in-
eraction with NR2 subunits may not be required for
ynaptic localization. NR2B-containing NMDARs lack-
ng PDZ binding domains are retained at the synapse if
he AP-2 internalization motif of NR2B is mutated or
P-2 binding to tyrosine motifs is blocked (Figure 2).
e see similar immunocytochemical results, with Y1472A/
1480A showing significantly greater colocalization
ith Bassoon compared to S1480A. In addition, a PDZ
inding domain mutant of NR2A localizes to the syn-
pse irrespective of mutation in the internalization motif
Figure 6). Retention at the synapse may, therefore, de-
end upon other proteins, such as the EphB receptor
Takasu et al., 2002), which has been shown to interact
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853Figure 7. Model Summarizing the Role of PDZ Proteins, AP-2-Mediated Internalization, and Phosphorylation by Fyn Kinase in the Regulation
of NR2B-Containing Receptors at the Synapse
NMDARs enter the postsynaptic density (gray shading) either through direct delivery or by lateral diffusion from extrasynaptic sites (arrows).
Fyn is recruited by the PDZ protein. Fyn facilitates the phosphorylation of Y1472 of NR2B and prevents AP-2 binding (inset). Removal of the
receptor from the synapse requires AP-2 binding. While AP-2 binding may occur at the synapse, internalization likely occurs at lateral
endocytic zones.Regulation of the NR2B Subunit
by Fyn Phosphorylation
Regardless of their role as anchoring molecules, PSD-
95 and other MAGUKs may play a critical role in recruit-
ing Fyn, which has been shown to be the predominant
kinase responsible for the phosphorylation of Y1472 of
the NR2B subunit (Nakazawa et al., 2001). PSD-95 as-
sociates with Fyn and brings the kinase into close prox-
imity to the NMDAR (Tezuka et al., 1999; Ali and Salter,
2001). Therefore, NR2B-containing receptors at the
synapse may require phosphorylation of Y1472 for re-
tention, which may occur if the receptor is in close
proximity to a Fyn/PSD-95 complex. If this is the case,
the PDZ interaction may not directly anchor NR2B-con-
taining receptors at the synapse, but rather may indi-
rectly anchor them by keeping PSD-95 and Fyn in close
proximity and, consequently, keeping Y1472 phosphor-
ylated and unable to interact with AP-2. In support of a
role of tyrosine phosphorylation in NMDAR trafficking,
tyrosine-phosphorylated NMDARs in the striatum are
enriched in the synaptic membrane and decreased in
intracellular membranes (Dunah and Standaert, 2001).
Blocking tyrosine phosphorylation also causes rela-
tively rapid internalization of extrasynaptic NMDARs (Li
et al., 2002). Furthermore, there is increased phosphor-
ylation of NR2B after LTP induction (Rostas et al., 1996,
Rosenblum et al., 1996), and Fyn mutant mice have im-
paired long-term potentiation, which can be rescued by
postnatal expression of Fyn (Kojima et al., 1997). Our
studies identify a function of Fyn in regulating internal-
ization and synaptic localization of NR2B-containing
NMDARs. This has critical functional consequences
since tyrosine phosphorylation of NR2B can be altered
in pain paradigms (Guo et al., 2002) with lithium treat-
ment (Hashimoto et al., 2002) and with ethanol treat-
ment (Alvestad et al., 2003). A recent study has also
outlined an ability of the Aβ peptide to induce internal-
ization of NMDARs and implicated dephosphorylationof Y1472 of the NR2B subunit, suggesting that the
phosphorylation state of this residue may have roles in
pathologic conditions (Snyder et al., 2005).
Regulation of Synaptic and Extrasynaptic NMDARs
Although NMDARs are concentrated at synapses, func-
tional NMDARs are known to localize at extrasynaptic
sites, with potential differences in the role of synaptic
versus extrasynaptic NMDARs. In particular, synaptic
NMDARs have been proposed to mediate signaling
pathways that promote neuronal survival, while extra-
synaptic NMDARs play a role in excitotoxicity (Har-
dingham and Bading, 2003). We have shown previously
(Prybylowski et al., 2002) that expression of NR2A WT
or NR2B WT subunits in CGCs causes a significant in-
crease in the amplitude of response to agonist applica-
tion (which activates all surface receptors) with no
change in the amplitude or frequency of NMDA-mEPSCs.
This provided evidence that while the extrasynaptic re-
ceptor population can be regulated by the total amount
of assembled complexes, the synaptic NMDAR popula-
tion is regulated independently of the availability of
subunit complexes.
We found in the present study that mutations in either
the PDZ binding domain or the YEKL motif of the NR2B
subunit similarly only affect the synaptic NMDAR pop-
ulation, without a significant effect on the whole-cell
response. It has been previously shown that a peptide
that blocks AP-2 binding to the GluR2 subunit of the
AMPAR does not alter basal synaptic AMPA transmis-
sion or affect total surface expression of AMPARs, but
these peptides block both NMDA-induced internaliza-
tion of AMPARs and long-term depression of synaptic
responses (Lee et al., 2002). Therefore, synaptic NMDA
and AMPA receptors may be specifically controlled by
internalization. Previous studies have suggested that
extrasynaptic NMDA receptors may also be regulated
by internalization (Li et al., 2002; Roche et al., 2001).
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does not influence extrasynaptic receptors, an interest-
ing possibility is that the internalization of synaptic and
extrasynaptic receptors involves different endocytic
motifs in the C termini of the subunits.
Subunit-Specific Regulation of NMDARs
Previous studies have shown that receptors containing
the NR2B subunit are regulated differently from those
containing the NR2A subunit (Cull-Candy et al., 2001).
NR2B-containing receptors are abundant at the syn-
apse early in development (Rumbaugh and Vicini, 1999;
Tovar and Westbrook, 1999; Townsend et al., 2003),
while with activity NR2A-containing receptors can re-
place NR2B-containing receptors (Barria and Malinow,
2002). In particular, introduction of light stimuli allows
rapid replacement of synaptic NR2B subunits with
NR2A subunits in the visual cortex (Philpot et al., 2001).
Distinct subunit composition of synaptic NMDARs has
been suggested to underlie differences in synaptic
plasticity (Liu et al., 2004). Our results suggest that the
differential regulation of NR2A- and NR2B-containing
receptors at the synapse may depend upon specific in-
teractions of NR2B with PDZ proteins and AP-2. Unlike
NR2B, we find that NR2A does not require a PDZ bind-
ing domain for synaptic localization and that NR2A sub-
units are not affected by mutations in their distal YKKM
motif (Figure 6). It has been shown previously that the
internalization motifs of NR2A and NR2B differ: NR2A
has a motif (YKKM) that is similar to the YEKL motif of
NR2B, but it is not a substrate for AP-2 binding (Lavez-
zari et al., 2003, 2004). Rather, internalization of the
NR2A subunit appears to involve a more proximal dileu-
cine motif (Lavezzari et al., 2004). We directly studied
the differences in NR2A and NR2B by generating the
construct NR2AMut5 that is identical to NR2A except
in its last 16 amino acids, which are identical to those
of NR2B. NR2AMut5 entered the synapse, but with mu-
tation of the serine of the PDZ binding domain (NR2A-
Mut6), this construct did not localize to the synapse.
Thus, mutation of the C terminus of NR2A involving
substitution of the amino acids of NR2B generates a
subunit that is dependent upon PDZ binding to localize
at the synapse.
Since the PDZ binding domains of NR2B and NR2A
are identical, our data on the ability of NR2A and the
inability of NR2B to traffic to the synapse in the ab-
sence of PDZ binding are surprising. However, other
findings in other studies could be attributable to differ-
ences in the PDZ interactions of these subunits. NR2A
knockout mice show a developmental loss of miniature
NMDA currents, which likely corresponds to loss of
NMDARs that are spatially closest to release sites
(Townsend et al., 2003). In contrast, electrically evoked
currents are maintained in these NR2A knockout mice,
suggesting that the remaining NMDARs (predominantly
NR2B-containing) are spatially more distant from re-
lease sites but can respond to glutamate diffusion pro-
duced by release of multiple vesicles. In addition, these
authors found a decreased binding of PSD-95 to NR2B
in the absence of NR2A. This led to a model suggesting
that activity-dependent insertion of PSD-95 into the





























































reads to a NMDAR-free “hole” in the synapse due to
oss of NR2B (Townsend et al., 2003). Our data provide
echanistic support for these findings and indicate
hat the NR2B subunit is under internalization pressure
n the absence of PDZ binding. Since the NR2A subunit
an localize to the synapse in the absence of PDZ bind-
ng, it suggests that this subunit may be relatively resis-
ant to changes in the postsynaptic density because it
oes not have the internalization behavior of NR2B.
vidence for Dynamic Regulation of Synaptic
MDARs by Internalization
ur studies on the interaction between the NR2B sub-
nit and AP-2 using a peptide corresponding to the dis-
al portion of the NR2B subunit, including the YEKL mo-
if but excluding the PDZ binding domain, revealed a
urprisingly rapid change in synaptic NMDA receptors.
nfusion of the peptide led to a significant increase in
he amplitude of the NMDA-mEPSC within 10 min (Fig-
re 4), suggesting a dynamic basal regulation of endog-
nous NMDARs by internalization. This time frame is
imilar to that reported for AMPA receptors after infu-
ion of a peptide that interferes with the interaction of
P-2 with GluR2 (Lee et al., 2002). While NMDARs at
he synapse have been thought to be relatively static
ompared to AMPARs (Malinow and Malenka, 2002),
here is evidence of changes in synaptic NMDARs
ithin a similar time frame. Rapid internalization has
een suggested previously for NMDARs, especially
uring early synapse development (Washbourne et al.,
004). Glycine priming has also been shown to produce
elatively rapid internalization of NMDARs (within 10
in), with a decline in synaptic NMDA response that
an be blocked with a peptide that inhibits clathrin-
ependent endocytosis (Nong et al., 2003). In addition,
hen synaptic NMDARs are irreversibly blocked with
K-801, there appears to be rapid lateral diffusion of
unctional NMDA receptors into the synapse, suggest-
ng that a large portion of synaptic NMDARs could be
xchanged in less than 10 min (Tovar and Westbrook,
002). Lateral diffusion is very likely to also play a role
n changes in synaptic NMDARs to allow the receptor
o move from the synapse to an extrasynaptic site
Choquet and Triller, 2003), as clathrin and endocytic
ones have been shown to be concentrated outside the
ostsynaptic density (Blanpied et al., 2002; Petralia et
l., 2003; Racz et al., 2004).
While the AP-2 complex is widely distributed (and im-
unolabeling can be found at the postsynaptic mem-
rane [Petralia et al., 2003; Racz et al., 2004]), phos-
horylation of the 2 subunit and association with
I[4,5]P2 is required for clathrin-dependent internaliza-
ion of proteins containing the YXXf motif (Nakatsu and
hno, 2003). Thus, two events could regulate the bind-
ng of AP-2 to NR2B: (1) the availability and phosphory-
ation state of the site on the receptor subunit, such as
EKL for NR2B, and (2) the availability and phosphory-
ation state of the proper adaptor subunit. Electron mi-
roscopy studies indicate that AP-2 resides signifi-
antly closer to the postsynaptic density than clathrin
r dynamin (Racz et al., 2004). Therefore, binding of
daptor proteins could occur within the PSD and mark
eceptor complexes for internalization at lateral endo-
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855cytic zones (Racz et al., 2004). Thus, reductions in
NMDA responses observed following changes in syn-
aptic activity may be linked to regulated endocytosis
(Montgomery and Madison, 2002).
Experimental Procedures
DNA Constructs
NR2B-Flag (NR2B subunit tagged at the N terminus with Flag epi-
tope, a gift of Dr. F. Anne Stephenson, UCL) has been previously
described (Hawkins et al., 1999). The cDNA was isolated from
mouse brain and has a sequence identical to that of GenBank
# D10651. The NR2A was a gift of Dr. Peter Seeburg (Max Planck
Institute), and a myc tag was placed immediately after its leader
sequence at amino acid position 23. All constructs were generated
with site-directed mutagenesis (QuikChange Site-Directed Muta-
genesis Kit, Stratagene) using NR2B-Flag or NR2A-myc as the tem-
plate. All constructs were verified by DNA sequencing. 2 WT and
2 W421A subunits of the AP-2 complex were gifts from Dr. Alexan-
der Sorkin (UCHSC). Fyn Y531F was a gift of Dr. Dorit Ron (UCSF).
Cerebellar Granule Cell Culture
Primary cultures of rat cerebellar granule cells (CGCs) were pre-
pared from postnatal day 7 (P7) Sprague Dawley rat cerebella (Pry-
bylowski et al., 2002). Cells were cultured in basal Eagle’s medium
supplemented with 10% fetal bovine serum (FBS), 2 mM glutamine,
and 100 g/ml gentamicin, with a final concentration of 25 mM KCl
(Invitrogen). To achieve functional synapse formation, on in vitro
day 5 (DIV5), media was replaced with low-potassium (5 mM) media
(MEM supplemented with 10 M cytosine arabinofuranoside, 5 mg/
ml glucose, 0.1 mg/ml transferrin, 0.025 mg/ml insulin, 2 mM gluta-
mine, and 20 g/ml gentamicin; Invitrogen). CGCs were transfected
on DIV5, using a modification of the calcium phosphate precipita-
tion technique (previously described in Prybylowski et al., 2002).
EGFP plasmid (Clontech) was cotransfected to allow visualization
of successfully transfected cells.
Immunoprecipitations
HEK 293 cells were transfected overnight using calcium phosphate
(Invitrogen). Cells were transfected with NR1-1a (previously de-
scribed in Prybylowski et al., 2002), PSD-95-GFP (gift of Dr. David
Bredt, UCSF), and NR2B cDNAs (at a ratio of 5NR1:10NR2B:1PSD-
95-GFP). Transfected cells were maintained with NMDAR antago-
nists (500 M ketamine and 2 mM kynurenic acid; Sigma) for 48 hr
after transfection. Cells were collected and solubilized with 1%
DOC (pH, 7.5) as previously outlined (Sans et al., 2000). Samples
were incubated overnight with Protein A agarose (Pierce), which
was precoupled (for 3 hr at 4°C with 10 l rabbit serum) either with
anti-PSD-95 (T60, previously described [Sans et al., 2000]) or with
preimmune IgG. Samples were then centrifuged and washed, and
the pellet was collected for standard Western blotting. Resulting
blots were incubated with monoclonal antibodies, including anti-
NR2B (Transduction Labs, 1:250), anti-GFP (Chemicon, 1:2000), or
anti-NR1 (clone 54.2, 1:4000). Goat anti-mouse secondary antibody
was used (Amersham), and blots were processed using the Amer-
sham ECL Plus kit.
Solutions and Drugs for Electrophysiology
The recording chamber was continuously perfused at a rate of 5
ml/min with an extracellular media composed of (in mM): 145 mM
NaCl, 5 mM KCl, 1 mM MgCl2, 1 mM CaCl2, 5 mM HEPES, 5 mM
glucose, 25 mM sucrose, 0.25 mg/l phenol red, and 20 M D-serine
(all from Sigma). Successfully transfected cells (2–4 days after
transfection) were visualized using GFP fluorescence. CGCs were
voltage clamped at −60 mV, and whole-cell recordings were per-
formed (using Axopatch 200; Axon Instruments). CGCs transfected
with 2 constructs were recorded at least 3–4 days after transfec-
tion to allow assembly into AP-2 complexes. A potassium gluco-
nate recording solution was used containing: 145 mM potassium
gluconate, 10 mM HEPES, 5 mM ATP-Mg, 0.2 mM GTP-Na, and 10
mM BAPTA, adjusted to pH 7.2 with KOH. Drug application was
done using a multibarrel pipette controlled by a stepper motor (SF-
77b; World Precision Instruments). To measure NMDA-mEPSCs,Mg2+-free extracellular solution with 1 M tetrodotoxin (TTX), 5 M
NBQX, and 50 M bicuculline (Sigma) was applied to the cell being
recorded. All experiments were performed at room temperature
(24–26°C). Data analysis of NMDA-mEPSCs was done as previously
described (Prybylowski et al., 2002) using Clampfit 9 (Axon Instru-
ments) and Minianalysis (Synaptosoft). For detecting NMDA-
mEPSCs, events that were larger than 9 pA were included (at least
two overlapping channel openings). NMDA-mEPSC averages were
determined from at least 30 events in each cell studied. Fitting of
the decay phase of averaged currents was performed using a sim-
plex algorithm for least-squares exponential fitting routines, and
we used a weighted mean decay time constant
tw = [If / (If + Is)] ∗ tf + [Is / (If + Is)] ∗ ts.
Single-channel current measurements were directly resolved
from the tails of NMDA-mEPSCs as previously described (Pryby-
lowski et al., 2002; Silver et al., 1992). Data values are expressed
as the mean ± SEM unless otherwise indicated. p values represent
the results of ANOVA analysis followed by a Bonferroni correction,
with p < 0.05 as the level of significance. Data between only two
experimental groups were analyzed with a Student’s t test, as
noted.
Imaging of Surface-Stained Neurons
Culturing of E18 hippocampal neurons using neurobasal media and
B27 supplement has been described (Sans et al., 2000). Transfec-
tions of Flag-tagged NR2B constructs were done with DIV14 neu-
rons using calcium phosphate, followed by staining 48 hr later.
Neurons were incubated with polyclonal antibodies against Flag
(Sigma) at 1:1000 in culture medium for 1 hr at room temperature
and then with indocarbocyanine (Cy3)-conjugated anti-rabbit anti-
body (Jackson ImmunoResearch Laboratories) at 1:1000 dilution
for 1 hr. Coverslips were then fixed with paraformaldehyde (4%)
and permeabilized with 0.025 Triton-X. Bassoon staining (Stress-
gen Bioreagents, British Columbia, Canada) was done at a 1:800
dilution of primary antibody for 1 hr followed by a 1:1000 dilution
of FITC-conjugated anti-mouse antibody (Jackson Immunore-
search Laboratories). Images were analyzed using Metamorph
software. For quantification, five 100 m dendritic regions were se-
lected from at least 11 transfected neurons (from two separate cul-
tures). Measurements from individual dendritic regions were first
grouped and averaged; means from different neurons in each
group were then averaged. Colocalization with Bassoon was de-
fined as having overlapping or adjacent pixels.
Peptide Studies
Peptides of the NR2B tail were generated by Princeton BioMole-
cules. One contained the YEKL motif (NGHVYEKLSSIE, YEKL pep-
tide) while the control peptide lacked the internalization motif
present in NR2B (NGHVAEKLSSIE, AEKL peptide). To allow normal
internalization in these experiments, they were performed with a
recording solution that lacked BAPTA. Recordings were done with
the peptide (100 M) included in recording solution containing pro-
tease inhibitors (1 g/ml each of aprotonin and leupeptin).
Yeast Two-Hybrid Protein Interaction Assay
The interaction between NR2B C-terminal tails (from aa 1315 to
1482) with various mutations at the YEKL motif (aa 1472–1475) and
the AP-2 2 subunit was investigated with a yeast two-hybrid in-
teraction assay. NR2B C-terminal sequences were subcloned into
the binding domain containing pGBKT7 vector. The AP-2 2 sub-
unit was subcloned into the activation domain containing pACTII
vector and the positive control TGN38 was subcloned into the
binding domain containing pGBT9 vector (original 2 and TGN38
constructs were gifts from Dr. Juan Bonifacino, NIH). AH109 yeast
cells (BD Clontech) were cotransformed with NR2B-containing vec-
tors (or TGN38 as a control) and 2 vector. After incubation at 30°C
for 2–5 days, the presence of blue colonies was an indication of an
interaction between the NR2B C terminus and the 2 subunit.
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